BRCA mutations are inextricably linked with breasts, but they can also lead to cancer in the pancreas, the prostate, and ...

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

women are at low risk for developing BRCA-mutation-associated breast or ovarian cancer. Furthermore, they found fair evidence of ethical, legal, and social harms associated with testing and cited ...

Methods We designed a rapid, digital pathway, supported by a genetics specialist hotline, for delivery of germline testing of BRCA1/BRCA2/PALB2 (BRCA-testing), integrated into routine UK NHS breast ...

Bonnie is in no doubt that when she reaches the age of eligibility, she will get the test. “It means that if I do have it, I can stop it before it gets bad,” she says. BRCA1 and BRCA2 are ...

Screening for pancreatic cancer is recommended for individuals with the above risk factors around 50 years of age or 10 years ...

Pancreatic cancer, a highly aggressive disease, often diagnosed late, has a low survival rate. Genetic testing provides ...

DNA testing revolutionizes metastatic castration-resistant prostate cancer prognosis, improving patient outcomes with faster ...